Effects of Selective Serotonin Reuptake Inhibitors on Auditory Processing: Case Study
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Auditory sensitivity and processing ability were evaluated in a patient who suffered from hyperacusis, difficulty understanding speech, withdrawn depression, lethargy, and hypersensitivity to touch, pressure, and light. Treatment with fluvoxamine and fluoxetine (selective serotonin reuptake inhibitors) reversibly alleviated complaints. Testing while medicated and unmedicated (after voluntary withdrawal from medication for several weeks) revealed no difference in pure-tone thresholds, speech thresholds, word recognition scores, tympanograms, or acoustic reflex thresholds. Medicated SCAN ● A (a screening test for central auditory processing disorders) results were normal, and unmedicated results were abnormal. Unmedicated transient otoacoustic emissions and auditory brainstem response waves I, III, and V were significantly larger bilaterally. Uncomfortable loudness levels indicated greater tolerance during the medicated condition. Central processing and vigilance were evaluated with analog-synthesized three-formant consonant-vowel syllables. While medicated, responses to stimuli at each ear revealed well-defined, labeling crossovers of about 90 msec. Vowel identification matched normal subject responses; labeling of /gE/jE/ and /bE/wE/ continua was well defined but all crossover points differed from normals (p < .0001). During unmedicated testing, responses to /gE/jE/ began at medicated levels but approached chance levels for the entire continuum within 10 min; labeling of /bE/wE/ was consistent with medicated responses throughout with earlier than normal crossover points. Abbreviations: ABRs = auditory brainstem responses, ALRs = auditory late potentials, CNS = central nervous system, GABA = gamma-aminobutyric acid, 5–HT = 5–hydroxytryptamine, OCB = olivocochlear bundle, SAS = sparse acoustic stimuli, SSRIs = selective serotonin reuptake inhibitors, TEOAEs = transient evoked otoacoustic emissions, UCL = uncomfortable loudness level
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hegerl, U., & Juckel, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90137-3 · Cited by 472
Davis, M., Strachan, D. I., & Kass, E. (1980) · Science · doi:10.1126/science.7394520 · Cited by 138
Cited by
Treatments for decreased sound tolerance (hyperacusis and misophonia)
Jastreboff, M., & Jastreboff, P. (2014) · Seminars in Hearing · doi:10.1055/s-0034-1372527 · Cited by 245
(2015) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-62630-1.00021-4 · Cited by 151
A review of hyperacusis and future directions: part II. Measurement, mechanisms, and treatment
Pienkowski, M., Tyler, R. S., Roncancio, E. R., Jun, H. J., Brozoski, T., Dauman, N., Coelho, C. B., Andersson, G., Keiner, A. J., Cacace, A. T., et al. (2014) · American Journal of Audiology · doi:10.1044/2014_aja-13-0037 · Cited by 138
Fackrell, K., Potgieter, I., Shekhawat, G. S., Baguley, D. M., Sereda, M., & Hoare, D. J. (2017) · BioMed Research International · doi:10.1155/2017/2723715 · Cited by 93
Metadata
- Authors
- Gopal, K. V., Daly, D. M., Daniloff, R. G., & Pennartz, L.
- Venue
- Journal of the American Academy of Audiology
- Publisher
- American Academy of Audiology
- Published
- 2000-09
- Volume
- 11
- Issue
- 08
- Pages
- 454-463
- ISSN
- 1050-0545 (ISSN-L)
- 2157-3107
- OpenAlex
- W20120414
- Cited by
- 37
- References
- 2
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Selective Serotonin Reuptake Inhibitors on Auditory Processing: Case Study. https://app.cochat.ai/papers/10.1055/s-0042-1748133
- The paper
- Gopal, K. V., Daly, D. M., Daniloff, R. G., & Pennartz, L. (2000). Effects of Selective Serotonin Reuptake Inhibitors on Auditory Processing: Case Study. Journal of the American Academy of Audiology. https://doi.org/10.1055/s-0042-1748133
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.